Analgesics market is expected to achieve growth by 2022, because of factors such as increase in cardiovascular disease, cancer, and arthritis and growing geriatric population.

Analgesics, also known as painkillers, are used to treat and reduce pain in the body. Typically, they are used when the pain is severe and becomes unbearable for the patient. Non-opioids, opioids, and compound analgesics (a combination of both opioids and non-opioids) are the major topical analgesic products used globally. The emergence of pain relief, pain management, and painkillers are mainly attributed to the increase in acute and chronic diseases, as well as the rising incidence of cancer worldwide.

Get the sample Report:

Global Analgesics Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $26.4 billion by 2022, registering a CAGR of 7.7% during the period 2015-2022. The non-opioids segment would continue to be the highest revenue-generating segment throughout the forecast period. North America and Europe, are likely to continue their lead through 2022; they collectively accounted for over half of the overall market share in the global analgesics market in 2015.

Frequent pain and aches experienced by the aging population, increasing incidences of cardiovascular disease (CVD), cancer, & arthritis, and rising investments in R&D by the public & private sectors, with the key focus on the classes of compounds to formulate new therapeutics, are the major factors boosting the market growth.

Purchase report @Discount:

However, factors such as uncontrolled prescriptions of opioids and drug abuse, leading to approximately 28,000 deaths in the U.S. every year, and insufficient regulatory guidelines, especially against opioid analgesics, are likely to impede the market growth. Furthermore, the increase in popularity of personalized medicine is expected to provide numerous growth opportunities for the analgesics market in the near future.

Key findings of Analgesics Market:
• Opioid analgesics are expected to grow at a CAGR of 7.1% during the forecast period.
• In the route of the administration market analysis, the transdermal analgesics segment is projected to grow fastest during the forecast period, whereas the oral analgesics segment is expected to grow at a CAGR of 1.5%.
• North America accounted for about one-third of the global analgesics market in 2015.
• The U.S. occupies the major market share within the North America market followed by Canada, together accounting for a market share close to 90.0% of the North American analgesics market.
• The Asia-Pacific region is anticipated to be the fastest growing analgesics market, followed by LAMEA region.
• Japan and China are the major market shareholders in Asia-Pacific with a combined market share of approximately 50% of the analgesics market in this region.

North America accounted for a major share of the overall analgesics market revenue in 2015, owing to a large number of pharmaceutical companies in this region. The analgesics market in developing economies, such as China and India, has numerous growth opportunities because of the availability of cheap raw materials and economical workforce.

The global analgesics manufacturers are relocating their facilities into developing economies by agreements or acquisitions with local players. Moreover, increasing use of analgesics in countries such as Nigeria, China, and India supports the growth of analgesics in developing economies.

The key companies profiled in the report are Bayer AG, Novartis AG, GlaxoSmithKline PLC, Pfizer Inc., Johnson & Johnson, Reckitt Benckiser (RB), Endo Pharmaceuticals, Bristol-Myers Squibb, Eli Lilly and Company, and Sanofi S.A.

About Us:-

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact Us:-

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.